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Abstract
Oxidized phospholipid species are important, biologically relevant, lipid signaling molecules that
usually exist in low abundance in biological tissues. Along with their inherent stability issues,
these oxidized lipids present themselves as a challenge in their detection and identification. Often
times, oxidized lipid species can co-chromatograph with non-oxidized species making the
detection of the former extremely difficult, even with the use of mass spectrometry. In this study, a
normal-phase and reverse-phase two dimensional HPLC-mass spectrometric system was applied
to separate oxidized phospholipids from their non-oxidized counterparts, allowing unambiguous
detection in a total lipid extract. We have utilized bovine heart cardiolipin as well as commercially
available tetralinoleoyl cardiolipin oxidized with cytochrome c (cyt c) and hydrogen peroxide as
well as with lipoxygenase to test the separation power of the system. Our findings indicate that
oxidized species of not only cardiolipin, but other phospholipid species, can be effectively
separated from their non-oxidized counterparts in this two dimensional system. We utilized three
types of biological tissues and oxidative insults, namely rotenone treatment of lymphocytes to
induce mitochondrial damage and cell death, pulmonary inhalation exposure to single walled
carbon nanotubes, as well as total body irradiation, in order to identify cardiolipin oxidation
products, critical to the cell damage/cell death pathways in these tissues following cellular stress/
injury. Our results indicate that selective cardiolipin (CL) oxidation is a result of a non-random
free radical process. In addition, we assessed the ability of the system to identify CL oxidation
products in the brain, a tissue known for its extreme complexity and diversity of CL species. The
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ability of the two-dimensional HPLC-mass spectrometric system to detect and characterize
oxidized lipid products will allow new studies to be formulated to probe the answers to
biologically important questions with regard to oxidative lipidomics and cellular insult.
Keywords
lipids; mass spectrometry; oxidative lipidomics; cardiolipin; apoptosis; high performance liquid
chromatography
1.1 Introduction
Oxidation of phospholipids and accumulation of their oxygenated intermediates have long
been considered as participants of two possibly interrelated processes: cell/tissue damage
and danger signaling [1]. However, direct experimental evidence supporting these views is
scarce, mostly due to technological difficulties in quantitative assessments of peroxidized
phospholipids. The traditional point of view is that oxidative stress causes – through yet to
identified mechanisms – random free radical peroxidation of phospholipids whereby the rule
of preferable oxidation of most polyunsaturated fatty acids dominates over the types of
phospholipids based on the specificity of their polar head-groups. In contrast, peroxidation
pathways catalyzed by specific catalysts – such as cytochrome c in apoptotic cells – should
non-randomly oxidize those classes of phospholipids that are localized in the immediate
proximity to the catalytic sites. Among those of particular interest in the context of
peroxidation reactions are cardiolipins (CLs), a critical phospholipid component of cellular
membranes from bacteria to mammals. In bacteria, CL is localized in the plasma membrane
while in mammals, CL is exclusively confined to the inner membrane of mitochondria [2].
While bacterial CL species are mostly saturated or monounsaturated [2], mammalian CLs
contain polyunsaturated fatty acid residues, hence are highly prone to oxidation [3-5]. The
importance of CL peroxidation in mammals is also emphasized by its critical role in the
function of numerous mitochondrial enzymes involved in electron transport chain function
and other proteins involved in energetic metabolism which include cytochrome c (cyt c)
oxidase [6], creatine kinase [7], ATP synthase [8] and the mitochondrial ADP carrier [9]
among others.
Our laboratory has pioneered the work describing the specific oxidation of CL which is
catalyzed by cyt c that acts as a CL-specific peroxidase in mitochondria during the early part
of the apoptotic program. Specifically, we have demonstrated that CL oxidation is required
for the release of cyt c and other pro-apoptotic factors into the cytosol and it is an important
step in the mitochondrial stage of apoptosis [10]. Since CL is sequestered primarily in
mitochondria of mammalian cells, it has also been viewed as a potent “danger signal” to the
immune system when tissue damage occurs as evidenced by the presence of anti-CL
antibodies in plasma of patients with a variety of diseases [11,12,13,14,15] and the report of
CL binding to the CD1 protein and stimulating a host T-cell response to bacterial lipids and
potentially host CL [16]. These results suggest that the CL-responsive T cells may play a
role in immune surveillance during infection and tissue injury. The fact that CL is a normal
component of plasma lipoproteins [17], suggests that the anti-phospholipid antibodies
present in various disease states, could recognize CL or oxidized CL in conjunction with
lipoproteins and/or plasma proteins. In addition, CL has been implicated as a modulator of
proteins like reactive protein c, acting as a cofactor thereby promoting its anticoagulant
activity [18].
As mentioned above, a high percentage of CL species that are found in mitochondria are
enriched in polyunsaturated fatty acids, making them excellent candidates for oxidation in
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general, and to cytochorme c-catalyzed peroxidation during apoptosis. A high degree of
structural variability of CL species exists depending upon the tissue in question, ranging
from a few major species in heart to over two hundred plus species in brain. Oxidized forms
of CL are now pursued with high interest due to their role in apoptosis via the activation of
cyt c peroxidase activity and eventual loss of mitochondrial permeability and asymmetry
[19,20] and as potential signaling markers that are released during cellular damage.
Analysis of oxidized lipids, especially peroxides, has become a daunting task in mass
spectrometry due to their low abundance, chemical and thermal instability and the potential
for further propagation of lipid oxidation and eventual degradation. Peroxidized lipids are
very prone to oxidation and degradation by heat and this characteristic was indeed an early
obstacle for their measurement which was overcome by the use of derivatization protocols.
Lately, liquid chromatography-mass spectrometry (LC-MS) has become an indispensable
tool for the analysis of lipids. Separation of lipids can be performed by normal and reverse
phase chromatography and numerous methods have been described. Normal phase
separation is based in adsorption and polarity of the lipids to the stationary surface whereas
in reverse-phase, hydrophobicity plays the major role. Both techniques have their
advantages and disadvantages. Normal phase chromatography allows separation of lipid
classes although both oxidized and non-oxidized species may overlap and the signals for the
low abundant (oxidized) species may be suppressed. While reverse-phase separation allows
for the separation of individual molecular species, multiple lipid classes may overlap. In the
case of CL and its oxidized products, additional difficulties arise due to their inherent
structural characteristics: the presence of two phosphate groups in the head group and four
fatty acyl moieties that give rise to multiple structural combinations. Therefore, only the
most abundant oxidized species are visible when samples of CL are run under normal phase
conditions.
The combination of both normal phase and reverse phase chromatography for the separation
of individual lipid species for each group was originally described by Pulfer [21] and this
approach has been utilized by several groups [22,23] although the literature in the area of
chromatographic separation and analysis of lipids and their oxidation products is extensive
[24-31]. Minkler and collaborators [32] recently developed a solvent system that resolved
individual CL species on a reverse-phase column. This system was also shown to be
applicable not only for the separation of intact forms of CL but also their oxidized species
[5].
In the present work, we show the ability to separate not only oxidized species of CL but
other classes of oxidized phospholipids first by separating phospholipids in a normal phase
system in the first dimension (1D) followed by a reverse-phase ion-pair based system for
separation in the second dimension (2D). We tested the power of this system to separate
oxidized and non-oxidized species of lipids in three different tissues; in human lymphocytes
treated with rotenone, in murine lung tissue after inhalation of single walled carbon
nanotubes (SWCNTs) and in gut (small intestine) tissue after total body irradiation. In
addition, we applied the 1D/2D LC-MS analysis on samples from rat brain, to further test
the system with a tissue containing extensive and diverse species of CL. The use of this
chromatographic protocol allowed us to characterize individual species for each
phospholipid and when present, their oxidized species, with a special emphasis on CL, in
lipid extracts from cells and tissues subjected to various insults. While the principle of non-
random peroxidation, specifically with regard to the preferential oxidation of CL and PS, has
been propagated in our previous work, the current work allows for better resolution of the
oxidized products and confirms that CL is one of the major substrates for the oxidative
process induced by a variety of cellular stresses, particularly those leading to apoptotic cell
death.
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2.1 Materials and Methods
2.1.1 Reagents
Chloroform (HPLC grade), bovine heart cardiolipin (BHC) and cyt c were purchased from
Sigma-Aldrich (St. Louis, MO, USA). Methanol, triethylamine, acetic acid and water were
all LC-MS grade from Fisher, Scientific (Pittsburgh, PA, USA).
Diethylenetriaminepentacetic acid (DTPA), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic
acid (HEPES), deoxycholate and soybean lipoxygenase (LOX) were also purchased from
Fisher Scientific. Phospholipid standards including tetralinoleoyl cardiolipin (TLCL) were
purchased from Avanti Polar Lipids (Alabaster, AL, USA).
2.1.2 Oxidation of CL and other phospholipids by cyt c and lipoxygenase as a model
system
Cyt c was used to oxidize TLCL in the following buffer: HEPES (20mM) pH 7.4, (DTPA
(100μM), TLCL (50μM) pH 7.4. Oxidation was started after addition of cyt c (5μM) and
H2O2 (100μM) and the reaction mixture was incubated for 1 hour at room temperature.
LOX was used for a more robust and efficient oxidation of CL in HEPES buffer (100mM)
pH 8.0, containing DTPA (0.5mM), deoxycholate (0.2%), and BHC (50μM). A similar
concentration of other lipids (phosphatidylcholine (PC), phosphatidylethanolamine (PE) and
phosphatidylserine (PS)) was utilized for their oxidations. LOX (15U/ml) was added to the
reaction system and incubated for 1 hour at room temperature. Samples were vortexed every
15 min to allow oxygenation of the solution to occur.
2.1.3 Lipid extraction
Lipid extraction was performed according to the Folch procedure described previously [33].
Briefly, choloroform:methanol (2:1) was added to the sample that was resuspended in KCl
(0.75%) in a ratio 5/1. The sample was kept on ice for 1 hour with vortexing every 15 min.
The organic layer was removed and filtered with Whatman number 4 filter paper (Whatman,
Inc., Piscataway, NJ) and dried over nitrogen. Samples were resuspended in the appropriate
1D or 2D solvent system.
2.1.4 1D separation of phospholipid species and LC-MS/MS analysis
Separation of individual phospholipid classes was accomplished by normal phase
chromatography using a silica column (Luna, 3micron, 15 cm × 2mm i.d. or a Luna 5
micron, 25cm × 2 mm i.d., Phenomenex, Inc., Torrance, CA). Phospholipids were eluted
from the column using the following solvent system: Solvent A:
chloroform:methanol:triethylamine:acetic acid, (80:19:0.5:0.5); Solvent B:
chloroform:methanol:water:triethylamine:acetic acid, (60:33.5:5.5:1:0.065). Flow was
maintained at 0.2 ml/min and a linear gradient of 0-100% B in 30 min was run (15 cm
column). Alternatively, the following gradient system was utilized: 0-6 min 100% A; 6-40
min 100% B; 40-50 min 100% B; 50-55min 100% A; 55-70 min 100% A (25 cm column,
0.3ml/min). Separation was performed at room temperature.
Fifty to eighty percent of the flow was diverted to a fraction collector while the remainder
was utilized for MS analysis. Chromatographic systems included either a Hewlett Packard
1050 liquid chromatograph (Hewlett Packard, Inc., Palo Alto, CA) or a Shimadzu
Prominence HPLC system (Shimadzu, Inc., Kyoto, Japan). Spectra were analyzed either on
a T7000 triple quadrupole mass spectrometer (ThermoElectron, Inc. San Jose, CA ) or on a
Waters Q-TOF mass spectrometer (Waters, Inc., Milford, MA). Parameters for the T7000
were as follows: spray voltage, 5.0 kV, negative mode; capillary, 250°C; sheath gas, 20 psi.
Spectra were collected in a data dependent mode. Tuning and collision energies were
optimized for individual phospholipid classes. Parameters for the Q-TOF were as follows:
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capillary voltage, 2.85 kV, negative mode; source temperature, 100°C; desolvation gas, 400
L/h; sampling cone, 60V; extraction cone: 4.5V; ion guide, 3.0V. Tuning was optimized for
all lipids across the scan range.
2.1.5 2D separation of phospholipid species and LC-MS/MS analysis
Fractions corresponding to individual phospholipid classes were collected from the 1D
separation, combined and dried over nitrogen. The lipids were dissolved in the appropriate
2D solvent (see below) and were subsequently analyzed in a second dimension system. For
CL, either a C8 column (5 micron, 4.6mm × 15 cm, Phenomenex, Inc.) or a C18 column (5
micron, 4.6mm × 15 cm, Phenomenex, Inc.) was used with either an isocratic solvent system
consisting of 2-propanol: water: triethylamine: acetic acid (45:5:0.25:0.25) or with a
gradient solvent system consisting of acetonitrile: water: triethylamine: acetic acid
(45:5:0.25:0.25, solvent A) and 2-propanol: water: triethylamine: acetic acid
(45:5:0.25:0.25, solvent B). The gradient program was as follows: 0-5 min 50% B; 5-10 min
65% B; 10-25 min 75% B; 25-45 min 95% B; 45-50 min 95% B; 50-55 min 50% B and
55-60 min 50% B for re-equilbration. Flow was maintained at 0.4 ml/min and analysis was
performed on a Waters Premier Q-TOF mass spectrometer. The remaining phospholipids
were analyzed on an ion trap mass spectrometer (LCQ-Duo, ThermoElectron, Inc.) using a
C18 column (Luna, 5 micron, 4.6mm × 15 cm, Phenomenex, Inc.) with a gradient that was
modified from a previously described solvent system [5] and was as follows: 0-5 min 50%
B, 5-15 min 80% B, 15-30 min 100% B, 30-45 min 100% B, 45-50 min 50% B, 50-55 min
50% B for re-equilibration of the column using a Spectra 6000 solvent delivery system
(Thermo-Electron, Inc.). Flow was maintained at 0.4 ml/min. In some experiments, data was
collected in a data dependent mode in which both MS and MS/MS acquisitions were
performed sequentially on the most abundant mass ions. Instrument conditions for the
Waters Premier Q-TOF mass spectrometer were as follows: capillary voltage, 2.85 kV,
negative mode; source temperature, 100°C; desolvation gas, 400 L/h; sampling cone, 60V;
extraction cone: 4.5V; ion guide, 3.0V. Tuning was optimized for all lipids across the scan
range. Instrument conditions for the ion trap analysis were as follows: capillary temperature,
250°C; spray voltage, 4.5 kV; sheath gas, 30 psi. All other tuning parameters were
optimized for each individual lipid class. All of the above separations were performed at
room temperature. Alternatively, using a smaller dimension C18 column (1.0 mm × 15 cm,
3 micron Luna 2 reverse phase, Phenomenex, Inc.), a modified solvent system was used
which consisted of solvent A: acetonitrile: water: triethylamine:acetic acid (45:5:0.25:0.25)
containing 0.01% formic acid and 5mM ammonium acetate and solvent B: 2-
propanol:water:triethylamine:acetic acid (45:5:0.25:0.25) containing 0.01% formic acid and
5mM ammonium acetate. Column temperature was 30°C and flow was maintained at 55 μl/
min on a Dionex Ulimate 3000 HPLC system (Thermo, Inc.). Spectra were acquired on a
Themro LXQ ion trap mass spectrometer (Thermo, Inc.) using a spray voltage of 5.0 kV and
a capillary temperature of 150°C. Scans were collected in a data dependent mode with an
isolation width of 1.5 Da and a normalized collision energy of 30 V. The HPLC gradient
was as follows: 0-5 min 50% B; 5-10 min 75% B; 10-25 min 85% B; 25-40 min 95% B;
40-50 min 95% B; 50-60 min 50% B and 60-70 min 50% B.
2.1.6 Treatment of lymphocytes with rotenone
Human peripheral blood lymphocytes were isolated from whole blood with the use of
Histopaque (Sigma-Aldrich, St. Louis, MO, USA) according to the manufacturer's
instructions. Monocytes were removed by their characteristic adherence to plastic (1h,
37°C). The non-adherent cells (human lymphocytes) were washed with PBS and incubated
with rotenone (250 μM) for 18h at 37°C. Cells were harvested and lipids were extracted
according to the protocol described above.
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2.1.7 Particles and exposure of mice to SWCNTs
SWCNTs were purchased from Carbon Nanotechnology (CNI, Houston, TX). The
nanotubes were manufactured using the high-pressure CO disproportionation process
(HiPco) and were used in the inhalation studies. The supplied SWCNTs contained
nanometer-scale Fe catalyst particles inherent in the HiPco process. Analysis indicates that
these SWCNTs contained elemental carbon (82% wt), Fe (17.7%). Trace elements present
included Cu (0.16%), Cr (0.049%), and Ni (0.046%). C57BL/6 mice were exposed to
SWCNTs via inhalation (5mg/m3, whole body inhalation for 4 consecutive days, 5 h/day)
[34]. All procedures were pre-approved and performed according to the protocols
established by the NIOSH Institutional Animal Care and Use Committee and the
Institutional Animal Care and Use Committee of the University of Pittsburgh.
2.1.8 Isolation of crude mitochondrial/synaptosomal (P2) fraction from rat brain tissue
Rats were perfused transcardially with ice-cold saline and then decapitated. Brains (minus
cerebellum) were rapidly removed and ipsilateral pericontusional cortex was isolated and
placed in ten volumes of ice-cold 0.32M sucrose in 1mM Tris buffer (pH 7.4). The tissue
was homogenized in a Teflon/glass homogenizer by ten gentle strokes. The homogenate was
spun at 1,000g for 10 minutes to remove nuclei and cell debris. The resulting supernatant
was centrifuged at 10,000g for 20 minutes to obtain the crude mitochondrial pellet. The
pellet was washed and centrifuged (4 minutes, 10,000g at 4°C).
2.1.9 Total body irradiation
Groups of C57BL/6NHsd female mice were irradiated to a dose of 9.5 Gy of total body
irradiation using a Shepherd Mark 1 Model 68 cesium irradiator at a dose rate of 80 cGy/
min as previously described [35]. The mice were sacrificed at 5 days post irradiation by CO2
inhalation. A 5-cm piece of small intestine was removed, cut open, washed in PBS to
remove fecal material, blotted dry and frozen in liquid nitrogen. All procedures were pre-
approved and performed according to protocols established by the Institutional Animal Care
and Use Committee of the University of Pittsburgh.
3.1 Results
3.1.1 First dimension separation of phospholipids
A total lipid extract from murine brain was separated by LC-MS using a normal phase
column in the first dimension. Excellent separation of phospholipid classes resulted as
shown in Figure 1. Ceramides and glycolipids eluted within the first four minutes of the
gradient. This was followed by phosphatidylglycerol (PG), CL, phosphatidylinositol (PI),
PE, PS, PC and sphingomyelin (SM). In this particular profile, a 1:1 split of the column
effluent was performed, diverting half of the flow to a fraction collector and the remaining
half to the mass spectrometer. Fractions containing individual phospholipid classes were
pooled, dried over nitrogen and dissolved in appropriate running solvent for chromatography
in the second dimension.
3.1.2 Second dimension separation of phospholipids
Individual classes of phospholipids from the first dimension chromatography were re-
chromatographed on a reversed-phase C18 column for the second dimension analysis.
Figure 2A displays the power of the second dimension system where PI, PG, SM and CL,
which eluted as one peak in the first dimension, were resolved into multiple peaks in the
second dimension. The dominant peak for PI (m/z 885, Fig. 2B) eluting at 19.1 min had a
fatty acyl chain composition of 18:0/20:4 upon MS/MS analysis. The dominant peak for PG
eluting at 20.6 min was identified as a 16:0/18:1 PG (m/z 747, Fig. 2B). The dominant SM
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species in brain (m/z 789, Fig. 2B) was identified as a d18:0/18:1 SM which eluted as an
acetate adduct. In contrast, while some degree of species separation was obtained with brain
CL (Figure 2A), multiple overlapping species still existed within each of the baseline
resolved peaks. A summed spectrum over all of these peaks (Fig. 2B) still displays extreme
complexity of this phospholipid in brain tissue.
3.1.3 Oxidized phospholipids elute at earlier retention times in the second dimension
system
One of the goals of this work was to develop a system that would separate oxidized
phospholipid species from non-oxidized phospholipid species. During a 1D elution of lipids
on a normal phase column, oxidized species can co-elute with non-oxidized species. Since
oxidized species usually exist in lower abundance, these biologically important lipids may
go undetected. While this partly depends upon the column chemistry chosen and the solvent
system utilized, our experience indicates that this is generally the case. In order to determine
whether or not the 1D/2D system would meet these requirements, we tested the system by
pooling individual phospholipid species of PC, PE and PS from the one dimensional run and
oxidizing them in the presence of LOX as indicated in the Materials and Methods section.
As shown in Figure 3A, oxidized species of PC, PE and PS eluted earlier (within the first 20
min retention time window) than their non-oxidized counterparts eluting after 20 min. These
results are in agreement with an increased hydrophilic character of the oxidized species
which should decrease their retention time in a reverse-phase system. Figure 3B indicates
the major non-oxidized masses of brain PC, PE and PS. Major species of PC included
16:0/16:0 PC, acetate adduct (m/z 792) and 16:0/18:1 PC, acetate adduct (m/z 818).
Additional major species of PE and PS are also noted. Some of the major oxidized species of
PE, PC and PS (Figure 3C) that were summed over the first 20 min retention time window
and eluted earlier than their non-oxidized species included m/z 822 (PE 18:0/22:6 +OO), m/
z 900 (PC 20:5 +O/22:6 +OO) and m/z 866 (PS 18:0/22:6 +OO), respectively. Oxidations
were confirmed by MS/MS analysis. One example is shown in Figure 3D where MS/MS
analysis of PS (m/z 866) indicated a fatty acyl composition of 18:0/22:6 +OO, indicating a
+32 Da increase in the 22:6 fatty acyl chain (m/z 359) which normally exhibits a mass at
327 Da. A fragmentation scheme is shown for the main fragments indicating the loss of
stearic acid (m/z 283), the loss of the serine from the head group (m/z 779) as well as the
loss of the oxidized fatty acid chain (m/z 359). The fragment at m/z 418 is a result of the
loss of both the serine residue from the head group and the oxidized fatty acid chain. The
species at m/z 761 indicates a loss of water.
3.1.4 Retention time of oxidized species of bovine heart cardiolipin (BHC) and TLCL in a
1D/2D separation system is dependent on the degree of oxidation
To further test the 1D/2D separation system, we oxidized TLCL as indicated in the Materials
and Methods section. As in the case with other phospholipid species tested, oxidized species
of TLCL exhibited earlier retention times (Figure 4A), this being dependent on the degree of
oxidation. Commercially available TLCL contains tetralinoleoyl CL (m/z 1448) as its
dominant CL species, with a minor sodiated species at m/z 1470 (Figure 4B). Oxidation can
be induced in the presence of cyt c and H2O2, as well as in the presence of LOX (Figure 4B,
C). The main oxidized products when cyt c was used consisted of hydroperoxy (m/z 1480)
TLCL. A small amount of monohydroxy TLCL (m/z 1464, Fig. 4B) existed as well as two
minor species consisting of hydroxy/hydroperoxy (m/z 1496) and di-hydroperoxy (m/z
1512) TLCL species (Figure 4B). All of the oxidized species eluted between 3 and 11 min,
well separated from the non-oxidized TLCL species eluting at 16 min on a C18 reversed-
phase column using an isocratic solvent system of 100% solvent B. On the other hand,
oxidation with LOX, a more robust oxidizing system, produced a shift in the chromatogram
(Figure 4C) to a more highly oxidized, earlier eluting species with a m/z of 1576 (Figure 4B)
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which consisted of TLCL with a combination of hydroperoxy and hydroxy modifications (+
128 Da increase).
Similar results were obtained when BHC was used as a substrate. Second dimension
separation of oxidized from non-oxidized CL species indicated oxidized products eluting
earlier (Figure 4C), which consisted of mono-hydroxy and mono-hydroperoxy BHC (m/z
1464 and 1480, respectively, Fig. 4D) as the major species when cyt c was used (Figure 4D).
Oxidation with LOX produced a chromatogram consisting of highly oxidized species
(Figure 4C), with the major peak eluting at 3.5 min. This peak contained a main species at
m/z 1576 (Figure 4D) which consisted of BHC with a mixture of peroxy and hydroxy
modifications. These results indicated that the 1D/2D system is capable of separating
oxidized species of CL from non-oxidized species. In addition, these results also indicated
that the 1D/2D system could then make the detection of low abundant oxidized CL species
possible.
3.1.5 Treatment of lymphocytes with rotenone induces oxidation of cardiolipin that is
detectable after 1D/2D LC-MS analysis
We next tested the 1D/2D system for its ability to detect oxidized species of CL after
treatment of lymphocytes with the pesticide, rotenone. Rotenone inhibits electron transport
chain function by interfering with the transfer of electrons from the iron-sulfur centers in
complex I to ubiquinone producing an increase in reactive oxygen species (ROS)
production. This mimics the mitochondrial death pathway via mitochondrial dysfunction
seen in many disease states. For these studies, human lymphocytes were treated with 250
μM of rotenone for 18h. Lipids were extracted and separated in a 1D system as described in
Materials and Methods. A total of 91 lipid species were identified between the first and
second dimension analyses. The CL fractions from the first dimension were isolated, pooled
and re-chromatographed in the second dimension utilizing, in this case, a C8 column using a
isocratic solvent system of 100% solvent B. We hypothesized that the oxidized species
would be in low abundance in this biological system. We reasoned that utilization of a C8
reverse-phase column would allow better concentration of oxidized species thereby
producing a higher signal to noise ratio. This results in the elution of CL-ox species in the
4-6 min retention time window and the CL species in the 6-8 min retention time window.
The CL species from lymphocytes eluted at 6.4 min in the second dimension (Figure 5A).
Our results indicated that human lymphocytes contained TLCL (m/z 1448) as their major
CL species (Figure 5B), although 11 species were identified. Treatment with rotenone
induced oxidation of CL, with two major species appearing at m/z 1464 (mono-hydroxy)
and m/z 1480 (mono-hydroperoxy/or di-hydroxy, Fig. 5C). These species, although in low
abundance, eluted between 4-5.5 min in the 2D system. Minor species indicating higher
degrees of oxidation were also detected. As expected, these species were undetectable in the
first dimension (not shown), due to the ion suppression produced by the more highly
abundant non-oxidized CL species. These results indicated that the 1D/2D system was
capable of detecting oxidized CL species from a biological model system. Interestingly, the
effect of rotenone on lipid oxidation appeared to be specific for CL as no other oxidized
lipids were detected in the 1D/2D system. This most likely reflects the specificity of
rotenone as a mitochondrial complex I inhibitor.
3.1.6 Exposure to SWCNTs induces oxidation of cardiolipin in murine lung tissue as
detected by the 1D/2D LC/MS system
Mice exposed to SWCNTs via inhalation were sacrificed on day 7. Lung tissue was
harvested and extracted for lipids. CL was isolated in the first dimension and analyzed in the
second dimension using the protocol described in this study. Using this protocol, we were
able to resolve non-oxidized from oxidized species of CL that differed significantly in their
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retention times. The non-oxidized CL profile from lung is shown in Figure 6A. Species at m/
z 1448, 1470 and 1476 have been previously identified as CLs with the following fatty acyl
composition: C18:2/C18:2/C18:2/C18:2, C18:2/C18:2/C18:2/C18:2 + sodium and C18:2/C18:1/
C18:1/C20:4 , respectively [35]. Both control and SWCNT samples displayed similar
chromatographic profiles with non-oxidized CL eluting at 6.5 min and oxidized CL species
eluting within the 4-6 min retention time window on the C8 column, again using an isocratic
solvent system of 100% solvent B (not shown). Summation of spectra within this oxidized
region indicated the presence of characteristic species of oxidized CL at m/z values of 1480,
1502 and 1508 at approximately a 3-fold higher intensity for the SWCNT exposed sample
(SWCNT treatment, day 7) as compared to control (control, Figure 6B). Controls displayed
only minor amounts of m/z species 1480 and 1502. These oxidized species at m/z 1480,
1502 and 1508 were generated from the non-oxidized CL species at m/z 1448, 1470 and
1476 with +32 Da increases reflecting mono-peroxy or di-hydroxy additions.
3.1.7 Whole body irradiation induces oxidation of CL in murine gut tissue as detected by
the 1D/2D LC-MS system
Mice receiving 9.5 Gy of whole body irradiation were sacrificed 5 days post-irradiation.
Small intestine tissue was harvested as described in Materials and Methods and processed
for lipid extraction. CL was isolated in the first dimension (not shown) and analyzed in the
second dimension utilizing the modified HPLC solvent system containing formic acid and
ammonium acetate on the 1.0 mm C18 column described in Materials and Methods. The
method utilizing this particular column and solvent system utilized a flow rate of 55 μl/min,
thus adding to the extended retention times for CL and CL-ox products. The small intestine
non-oxidized CL for the irradiated sample eluted in a series of peaks in the reverse-phase
system over a retention time of 30-40 min and consisted of 5-6 main CL clusters (Figure
7A). Summation of spectra in the CL-ox region (20-30 min retention time) indicated two
mass ions at m/z 1464 (25.7 min) and 1480 (23.3 min), which correlated with their base
peak chromatograms (Figure 7B). We compared these results from irradiated tissue to a
model system where CL was oxidized with cyt c and H2O2 as described in Materials and
Methods. Indeed, oxidized CL eluted within the 20-30 min retention time window with
corresponding mass ions at m/z 1464 and 1480 (not shown). When we compared
fragmentation patterns of mass ions with m/z 1480 and 1464 from our model system to the
same mass ions seen in the irradiated small intestine sample, similar fragmentation patterns
were seen. The m/z 1480 ion from the irradiated tissue displayed linoleic acid as one of the
fatty acyl chains (m/z 279) as well as fragment ions at m/z 695 and 727, all which are seen
in the TLCL sample oxidized with cyt c/H2O2 (Fig. 7C,a), indicating that oxidation had
occurred as determined by the +32 Da mass increase. A fragmentation scheme is shown
above for the main fragments indicating the loss of the oxidized fatty acyl chain (m/z 311),
the loss of one oxidized phosphatidic acid (PA) structure (m/z 727) and one non-oxidized
PA structure (m/z 695) as well as the loss of linoleic acid (m/z 279). In addition, the
daughter ion spectrum of the m/z 1464 mass ion from the irradiated tissue also displayed the
same fragments at m/z 695 and 711 indicating a +16 Da mass increase, analogous to the
TLCL sample oxidized with cyt c/H2O 2 containing one linoleic (m/z 279) and one hydroxy
linoleic fatty acyl chain (m/z 295, Fig. 7C,b). A fragmentation scheme is also shown above
for the main fragments indicating the loss of hydroxy-linoleic acid (m/z 295), linoleic acid
(m/z 279) as well as one oxidized and one nonoxidized PA structure (m/z 711 and 695,
respectively). The fragment at m/z 415 indicates m/z 695 minus linoleic acid. Thus, it was
concluded that the CL species at m/z 1464 and 1480 in the irradiated tissue was oxidized as
determined from their respective retention times and fragmentation patterns.
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3.1.8 Evidence for CL oxidation in normal rat brain tissue
We next determined whether the 1D/2D LC-MS system could be applied to normal brain
tissue, where the complexity and diversity of CL species is apparent. Crude mitochondrial
fractions were isolated from rat brain tissue and lipids were extracted. CL was isolated in the
first dimension and re-chromatographed in the second dimension system. Figure 8 (top
panel) displays the 2D LC-MS chromatogram in which the non-oxidized CL eluted within
the 6-8 min retention time window using a C8 column with 100% solvent B. The spectrum
for the non-oxidized CL species (Fig. 8, bottom right panel) displays the extreme diversity
of brain CL with 8 clusters of CL signals within the m/z 1340 to 1540 range. Also seen in
the normal brain was a small amount of CL-ox species, which eluted within the 4-6 min
retention time window (Fig. 8 bottom left panel). Interestingly, these species fell within a m/
z range of 1540 to 1680. While these species were in too low abundance for structural
identification, preliminary experiments with an in vitro model system (not shown) indicated
that one of the major species (m/z 1552) suggested the presence of two linoleic chains with
hydroxy/peroxy modifications (+ 48 Da per chain). It should be noted here that tissue
homogenization can, in some cases, be a potential causative agent for oxidation. However,
this is usually associated with excessive handling/homogenization of tissue which was not
the case in these studies. Here, a glass Dounce homogenizer was used to deliver only ten
gentle strokes for tissue disruption. Oxidation induced by homogenization would have
undoubtedly resulted in the accumulation of peroxidation products in most of the
polyunsaturated lipids, which was not the case in these studies. These results suggest that
CL oxidation products can be assessed in tissues such as brain, containing a high degree of
CL complexity and diversity. In addition, significantly elevated levels of CL-ox have been
observed after traumatic brain injury (Jing, et al, submitted), [36], lending support to the
non-random and specific, rather than nonspecific, character of the oxidative process.
4.1 Discussion
Peroxidation of lipids is believed to occur through two major pathways: 1) a non-enzymatic
free radical process and 2) an enzymatic reaction process where radical intermediates are
“caged” within the regulated protein environment [37]. The two most prominent features of
non-enzymatic peroxidation are 1) its random character with regards to the major classes of
phospholipids whereby specificity is driven by the degree of unsaturation of the substrates
[38,39], and 2) a plethora of different oxidation products from hydroperoxides to carbonyl
compounds and truncated species formed as a result of beta-scission [37]. By contrast,
enzymatic peroxidation is specific with regards to both oxidation substrates as well as
reaction products. Until recently, a detailed characterization of these most important
characteristics of peroxidation, with a notable exception of oxygenated fatty acids,
represented an extremely challenging and in many cases, an almost impossible task. With
the advent of mild ionization techniques and contemporary MS protocols, these
technological issues slowly find their solutions and characterization of lipid peroxidation
products in complex biological mixtures becomes a more realistic goal.
Here, we have utilized a normal phase/reverse-phase two dimensional HPLC MS/MS
method for the analysis of oxidized lipid species, especially as it applies to CL. We first
tested the 2D separation system with CL oxidized in the presence of cyt c/H2O2 as well as
with LOX. Oxidized CL species were clearly separated from non-oxidized species in the
second dimension due to their increased hydrophilicity. In addition, elution profiles
correlated with the degree of oxidation, with the more highly oxidized species eluting first.
The 1D/2D system was also tested on PC, PE and PS species isolated in the first dimension
from a total brain lipid extract. These isolated phospholipid classes were then treated with
LOX to induce oxidation. The products of the reaction were then re-chromatographed in the
second dimension. As seen in the case of CL and oxidized CL, all oxidized species of PC,
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PE and PS were clearly separated from the non-oxidized species and eluted at earlier time
points on the reverse-phase system, indicating that this system could be utilized for all
phospholipid classes. Oxidation of TLCL or BHC with cyt c/H2O2 produced oxidized
species mainly consisting of hydroxy and hydroperoxy species. A more robust oxidation was
seen when LOX was used which generated higher degrees of oxidation across all fatty acyl
chains as evidenced by the increased mass of the oxidized products.
We further tested the system with four biologically relevant model systems in four different
tissue settings. The first model system involved the treatment of human lymphocytes with
the pesticide rotenone, an agent known to induce mitochondrial damage via complex I and
increased ROS. Our results indicated that oxidized CL species eluted earlier and were
clearly separated from non-oxidized CL species. Two major CL oxidations occurred with
rotenone treatment and included hydroxylations and peroxidations, mainly associated with
the oxidizable linoleic fatty acyl chains. Oxidations in other lipids were not detected most
likely due to the direct effect of rotenone on mitochondrial complex I activity, resulting in
an increase in ROS, an oxidative event which is biased toward CL. This strongly suggests
that in the rotenone/lymphocyte system, oxidation of CL is a non-random event, occurring
within two CL species, all containing two or more linoleic fatty acyl chains.
Our second system involved a biologically different but relevant SWCNT inhalation model.
Here, CNT inhalation caused an enhancement of two oxidized CL species at m/z 1480, 1502
(sodium adduct) and 1508. These represented +32 Da increases from their respective parent
masses indicating di-hydroxy and/or monoperoxy modifications. Here again, oxidation
appeared to be specific (biased mostly toward oxidation of linoleic species) strongly
suggesting a non-random pattern of oxidation.
Our third system involved the effect of radiation on gut (small intestine) tissue. Here, we
identified two oxidized species of CL (m/z 1464 and 1480) five days after radiation
exposure. Fragmentation of these species indicated that hydroxy (m/z 1464) and di-hydroxy/
monoperoxy (m/z 1480) modifications were present. Linoleic fatty acyl chains were once
again identified as the target of oxidation. The presence of oxidized species of CL was also
confirmed by their decreased and essentially identical retention times in the 2D reverse-
phase system to that of CL oxidized in the presence of cyt c/H2O2.
Finally, we were able to assess oxidized CL within normal rat brain tissue. Oxidized CL
species were detected in this tissue despite their low abundance. Unlike lymphocyte, lung
and small intestine, oxidized CL species in brain appear at much higher m/z values. While
this is most likely due to the extreme diversity in CL species in this tissue, the results still
converge on linoleic fatty acyl chains as one of the main targets of oxidative attack. A
comparison between oxidized CL species generated in vitro in a model system with cyt c
and LOX versus those species found in rotenone-treated lymphocytes, SWCNT inhalation,
whole body irradiation and normal brain tissue indicates a preference or bias toward the
involvement of enzymatic pathways of oxidation over non-enzymatic pathways. The
specificity and substrate preference found in all four biological samples strongly implies that
non-random oxidation is the driving force behind these processes. In all of these cases it
should be explained that the non-random oxidation process that is referred to here are those
species of CL and PS that appear to be specifically susceptible to oxidation despite the fact
that other oxidizable phospholipids are plentiful, containing multiple double bonds in their
fatty acyl chains. Still, CL and PS with lower levels of polyunsaturated fatty acids present
themselves as the main phospholipid species that are oxidized. With respect to CL, the
number of oxidation products is directly related by the abundance and most likely the
particular species of CLs that interact with cyt c.
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Structural analysis indicated that oxidations of CL containing linoleic fatty acyl chains were
most common, which included hydroxy and monoperoxy/di-hydroxy modifications. While
other polyunsaturated fatty acyl chains exist, which are all susceptible to oxidation, it is
interesting to speculate as to why the linoleic fatty acyl chain is favored in CL. One obvious
reason would be because of its higher abundance. However, location of the particular CL
species as well as the substrate preference of the oxidative enzyme system may also be
partially responsible. It is interesting to note that other mitochondrial lipids, such as PG,
containing linoleic fatty acyl chains, were not oxidized as determined by this system. This
suggests a specific oxidative preference toward CL. However, the potential of rapid
remodeling for other mitochondrial lipid species containing oxidized fatty acyl chains may
also exist.
In this study, CL oxidation was noted in three different biological systems and in four
representative tissues. A plausible explanation for these results may be that oxidized CL
functions as both a signaling molecule and as a danger signal for damaged tissue with the
degree of oxidation and the particular species oxidized playing a key role in this regard.
While the current study represents an improvement in the analysis and characterization of
oxidized lipid species, progress in the area of quantitation of these species is recognized and
is still needed. Much of the difficulty in this area stems from the lack of proper oxidized
phospholipid standards. The number of different phospholipid oxidation products can be
enormous such that the number of oxidized standards that are needed become almost
impractical to obtain. Commercial standards for various oxidized phospholipids are
extremely scarce and are severely limited in scope. While in vitro oxidation of phospholipid
classes can be considered as potential sources of standards, controlling the type and extent of
oxidation is difficult and there is no guarantee that these in vitro oxidations will directly
mimic those seen in a particular biological system. The authors recognize this shortcoming
with regard to quantitation of oxidized phospholipid species and as a result, we are
developing alternative biochemical/enzymatic approaches that could potentially circumvent
the problem of quantitation of oxidized lipids species. The major intent of this approach is to
convert myriads of possible phospholipid peroxidation products into a manageable number
of different oxygenated PUFA. In this case, lipid extracts could be treated with a
combination of phospholipases to remove oxidized fatty acid chains (lipoprotein
phospholipase A2, secreted) and non-oxidized fatty acid chains (secreted/cytosolic
phospholipase A2). With the more readily available oxidized fatty acid standards, the
analytical/quantitative power of the system can be improved remarkably by employment of
this approach with a total lipid extract to quantitate the total amount of oxidation sites. The
enzymatic approach could then be applied to individual phospholipid classes after 1D
separation for a more selective distinction of oxidation products. Additionally, comparison
of the levels of isoprostanes and lipid peroxidation products would allow for the
discrimination between random, non-enzymatic pathways and that of specific enzymatic
pathways in damaged tissue. This would allow for the development of more efficient
therapies against oxidative stress related diseases.
With the application of the 1D/2D HPLC-MS system, a variety of questions can now be
formulated to probe the answers to a variety of biologically important questions with regard
to oxidative lipidomics.
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Abbreviations
HPLC high performance liquid chromatography
LC-MS liquid chromatography-mass spectrometry
Q-TOF quadrupole-time of flight
ADP adenosine dinucleotide diphosphate
NDPK nucleoside diphosphate kinase
CCI control cortical impact
CL cardiolipin












PBS phosphate buffered saline
TBI traumatic brain injury
1D 1st dimension
2D 2nd dimension
ROS reactive oxygen species
SWCNTs single-walled carbon nanotubes
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• Oxidized lipids have been separated from non-oxidized lipids using a 2D
HPLC-MS system
• Oxidized CL species have been detected in four different tissue settings
• Oxidation of CL is a non-random process
• Similar oxidized CL species appear with different biological insults
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Figure 1. First-dimension (1D) separation of rat brain phospholipids by normal-phase HPLC-
MS/MS
Lipids were extracted from rat brain tissue (non-mitochondrial enriched) and were subjected
to 1D LC-MS analysis on a normal phase column. Individual lipids classes were identified
based on retention times and MS/MS analyses. Major phospholipid and glycolipid fractions
eluted in the following order; ceramide/glycolipids, PG, CL, PI, PE, PS, PC/PA, SPH as
indicated. A base peak intensity plot is shown.
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Figure 2. Second-dimension (2D) separation of rat brain phospholipids by reverse-phase HPLC-
MS/MS
Individual fractions corresponding to PI, PG, SPH and CL were from the 1D analysis were
pooled based on phospholipid class and re-chromatographed in the 2D C18 reverse-phase
system. Lipids were identified based on retention time and MS/MS analysis. The following
rat brain phospholipid classes which eluted as essentially single peaks in the 1D system,
were resolved into the following number of peaks in the second dimension: (PI, 6), (PG, 3),
(SPH, 5) and (CL, 4), 2A. Chromatograms for PI, PG and SPH. The chromatogram for CL
was collected in full MS mode. Summed spectra across all peaks for each phospholipid class
are shown in 2B.
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Figure 3. Second dimension (2D) analysis of brain PC, PE and PS oxidized in the presence of
lipoxygenase
A total rat brain lipid extract was chromatographed in the 1st dimension. Fractions
corresponding to individual phospholipid classes were pooled, oxidized with lipoxygenase
and chromatographed in the second dimension system using a C18 colum. Lipids were
identified based on retention time and MS/MS analysis. In all cases, oxidized species eluted
at earlier retention times as compared to their non-oxidized counterparts. 3A:
Chromatograms for PC, PE and PS. 3B: Spectra from the individual 2D chromatograms for
non-oxidized PC, PE and PS were summed over the retention times associated with the non-
oxidized species and are as follows; PC (22-28 min), PE (22-33 min) and PS (20-32 min).
3C: Spectra from the individual 2D chromatograms for oxidized PC, PE and PS were
summed over the retention times associated with the oxidized products and are as follows:
PC (10-18 min), PE (6-20 min) and PS (6-18 min). 3D: MS/MS analysis was performed on
the oxidized PS species (m/z 866). Fatty acyl chain analysis is shown with an oxidation of a
22:6 fatty acid chain (m/z 359) indicating the addition of two oxygens. A fragmentation
scheme is shown for the main fragments indicating the loss of stearic acid (m/z 283), the
loss of the serine residue (m/z 779) as well as the loss of the oxidized fatty acid chain (m/z
359). The fragment at m/z 418 is a result of the loss of both the serine residue from the head
group and the oxidized fatty acid chain.
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Figure 4. Treatment of TLCL and BHC with cyt c/H2O2 and LOX induces products with
varying degrees of oxidation
4A: TLCL was oxidized with cyt c/H2O2 as described in Materials and Methods and
chromatographed on the 2D system on a C18 column (isocratic, 100% sovent B). Increased
oxidation correlated with decreased retention time. 4B: TLCL was oxidized either with cyt
c/H2O2 or with LOX as described in Materials and Methods. Oxidation with cyt c was
biased toward di-hydroxy and/or monoperoxy (m/z 1480) species. Monohydroxy (m/z
1464), monoperoxy/hydroxy (m/z 1496) and dihydroperoxy (m/z 1512) species represented
minor modifications. Oxidation with LOX produced numerous species of highly oxidized
TLCL, one of which contained a combination of peroxy/hydroxy modifications (m/z 1576).
4C: 2D chromatograms of BHC and TLCL treated with LOX. Oxidized products of BHC
and TLCL eluted at earlier retention times (3- 11 min) than their non-oxidized counterparts
eluting at 16-19 min. 4D: Mass spectra of BHC and its oxidation products after treatment
with cyt c/H2O2 or LOX. Major oxidized products resulting from treatment with cyt c/H2O2
(m/z 1464 and 1480) or LOX (m/z 1576) are noted.
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Figure 5. Treatment of human lymphocytes with rotenone induces monohydroxy and
monoperoxy modifications of mitochondrial CL
5A: Human lymphocyte contained tetralinoleoyl CL (m/z 1448) as its major CL species
which eluted at 6.45 min in the second dimension system (C8 column, 100% sovent B).
Lymphocytes treated with 250 μM rotenone (Ro) for 18h also displayed oxidized species
eluting between 4-6 min. 5B: Non-oxidized CL spectrum from lymphocytes. 5C: Spectrum
of CL-ox from lymphocytes treated with rotenone. Monoperoxy (m/z 1464) and
hydroperoxy (m/z 1480) were the dominant oxidized CL species. Elemental compositions
for CL masses are as follows: 1421.9443, C79H139O17P2; 1447.9654, C81H141O17P2;
1464.9632, C81H141O18P2; 1479.9638, C81H141O19P2.
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Figure 6. Inhalation of SWCNT's induces CL oxidation
Murine lung tissue was harvested on day 7 after four days of SWCNT exposure (5h/day).
Lung tissue was extracted for lipids and analyzed on the 1D/2D LC-MS system (C8 column,
100% solvent B). 6A: non-oxidized CL spectrum.6B: Increases in CL-ox species (m/z 1480,
1502 and 1508, which eluted in the CL-ox retention time window (4-6 min), were noted.
Elemental composition for CL masses are as follows: 1395.9331, C77H137O17P2;
1423.9635, C79H141O17P2; 1447.9660, C81H141O17P2; 1475.9931, C83H145O17P2;
1497.9871, C85H143O17P2; 1519.9675, C87H141O17P2.
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Figure 7. Second dimension (2D) analysis of CL from irradiated murine small intestine
Mice were exposed to whole body irradiation and lipids were extracted from murine small
intestine tissue and were subjected to 1D LC-MS analysis on a normal phase column. The
CL fraction from the 1D run was re-chromatographed in the 2D on a 1.0mm C18 column
(full gradient). 7A: The base peak chromatogram indicated a separation of non-oxidized CL
species which eluted within the 30-40 min retention time window. A summed spectrum is
also shown for the non-oxidized CL. 7B: 2D analysis of CL from irradiated small intestine.
Base peak chromatograms for m/z 1464 and m/z 1480 are shown along with a summed
spectrum from the oxidized region (22-27 min retention time window, inset). 7C: LC-MS/
MS analysis of m/z 1480 and m/z 1464 species from TLCL oxidized with cyt c/H2O2. (7C,a
and 7C,b, respectively). A fragmentation scheme is shown above for the main fragments of
m/z 1480 (7C, a) indicating the loss of the oxidized fatty acyl chain (m/z 311), the loss of
one oxidized phosphatidic acid (PA) structure (m/z 727), one non-oxidized PA structure (m/
z 695) as well as the loss of linoleic acid (m/z 279). A fragmentation scheme is also shown
above for the main fragments of m/z 1464 (7C, b) indicating the loss of hydroxy-linoleic
acid (m/z 295), linoleic acid (m/z 279) as well as one oxidized and one nonoxidized PA
structure (m/z 711 and 695, respectively). The fragment at m/z 415 indicates m/z 695 minus
linoleic acid.
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Figure 8. Assessment of oxidized CL species in normal rat brain tissue
Lipids were extracted from rat brain tissue and fractionated on the 1D LC-MS system. The
CL fraction was collected and re-chromatographed in the 2D system (C8 column, 100%
solvent B). Fig. 8, top panel: The 2D CL base peak chromatogram indicated a separation
CL and CLox species. Fig. 8, bottom right panel: Representative spectrum for non-
oxidized brain CL. Fig. 8, bottom left panel: Representative spectrum for oxidized brain
CL. Elemental composition for CL masses are as follows: 1345.9111, C73H135O17P2;
1373.9478, C75H139O17P2; 1399.9681, C77H141O17P2; 1427.9907, C79H145O17P2;
1449.9856, C81H143O17P2; 1475.9945, C83H145O17P2; 1449.9953, C85H145O17P2;
1523.9994, C87H145O17P2.
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